过去一年中添加的文章,按日期排序

Fisetin reduces the resistance of MOLT-4 and K562 cells to TRAIL-induced apoptosis through upregulation of TRAIL receptors

L Liu, SA Hussain, X Hu - Naunyn-Schmiedeberg's Archives of …, 2024 - Springer
2 天前 - clinical trials, resistance to TRAIL-induced apoptosis is a major challenge ahead of
this therapy in various cancer models … facilitate the application of TRAIL in cancer therapies. …

Modified traditional TNM staging of pyriform sinus and hypopharyngeal and laryngeal cancer based on lymph node ratio and its clinical significance: a population …

J Yue, H Cai, G Zhang, X Wei, Y Jin, Y Sun… - International Journal of … - journals.lww.com
2 天前 - … To evaluate the application value of a new TLNRM staging prediction model
based on … ) in patients with Pyriform Sinus and Hypopharyngeal and Laryngeal cancer (PHLC). …

[PDF][PDF] Breast Cancer Classification using Neural Networks

V Garg, S Maggu, B Kapoor - researchgate.net
2 天前 - … In this project, the breast cancer dataset is obtained … cancer classification model
utilizing neural networks and evaluates its performance using the Wisconsin Breast Cancer

Unsupervised Bayesian Generation of Synthetic CT from CBCT Using Patient-Specific Score-Based Prior

J Peng, Y Gao, CW Chang, R Qiu, T Wang… - arXiv e …, 2024 - ui.adsabs.harvard.edu
2 天前 - clinical settings. Purpose: This work aims to develop an unsupervised learning
method using the patient-specific diffusion model … ) cancer, pancreatic cancer, and lung cancer. …

A prognostic nomogram to predict the cancer-specific survival of patients with initially diagnosed metastatic gastric cancer: a validation study in a Chinese cohort

Z Zhao, E Dai, B Jin, P Deng, Z Salehebieke… - Clinical and …, 2024 - Springer
3 天前 - cancer (mGC). Therefore, the objective of this study was to construct and validate
a new nomogram model to predict cancer-… net benefit in prediction and clinical applications. …

Industry News (Jan 2024 to May 2024)

F Wang - Journal of Organoid and Bioscience, 2024 - jobs.isoor.org
3 天前 - … advancements and applications of organoid models. … cancer. Notably, for the
first time, it includes patient-derived organoid (PDO) drug sensitivity testing to enhance clinical

Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD

Q Zhou, Y Liu, Y Gao, L Quan, L Wang… - Pharmacogenomics and …, 2024 - dovepress.com
3 天前 - … used in clinical applications. Therefore, … in cancer of the lungs. We evaluated the
functions of cuproptosis and lncRNA in cancer of the lungs and created a risk prediction model

[HTML][HTML] Development of a risk prediction model for radiation dermatitis following proton radiotherapy in head and neck cancer using ensemble machine learning

TF Lee, YH Liu, CH Chang, CL Chiu… - Radiation …, 2024 - ro-journal.biomedcentral.com
3 天前 - … Therefore, the practical utility of these predictive models in clinical settings requires
… potentially more accurate approach for clinical applications, pending further validation. …

Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors

X Wang, W Wang, S Zou, Z Xu, D Cao, S Zhang, M Wei… - Cell Research, 2024 - nature.com
3 天前 - cancer. However, no objective clinical responses were observed. Therefore, whether
the … Using this animal model, we demonstrated that the KRAS G12V mRNA vaccine could …

Artificial Intelligence for Non-Melanoma Skin Cancer

MH Trager, ER Gordon, A Breneman, C Weng… - Clinics in …, 2024 - Elsevier
4 天前 - … AI models have also been used in conjunction with clinical, histologic and molecular
data to predict patient outcomes. Smartphone applications integrating AI applications to …